Dr. Leguay is involved in experimental design, direct implementation of experiments, and data analysis, specifically, characterizing functions of stem cell pathway proteins in lung cancer and mesothelioma cells, correlating gene expression signature and clinical outcomes in cancer patients, and preparing manuscripts.